Performance of the Aptima High-Risk Human Papillomavirus mRNA Assay in a Referral Population in Comparison with Hybrid Capture 2 and Cytology

Human Papillomavirus Types 16 and 18 mRNA Levels and Not DNA Levels May be Associated With Advancing Stages of Cervical Cancer

(2010) Manu Gnanamony et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Efficiency of the APTIMA® HPV Assay for detection of HPV RNA and DNA targets

(2009) Damon Getman et al.   JOURNAL OF CLINICAL VIROLOGY

Clinical performance of the APTIMA® HPV Assay for the detection of high-risk HPV and high-grade cervical lesions

(2009) Janel Dockter et al.   JOURNAL OF CLINICAL VIROLOGY

Comparison of Predictors for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears

(2008) A. Szarewski et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Test positivity cutoff level of a high risk human papillomavirus test could be increased in routine cervical cancer screening

(2008) Laura Kotaniemi-Talonen et al.   INTERNATIONAL JOURNAL OF CANCER

Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions

(2007) T. YOSHIDA et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER